UConn Health
Isolating Their Target
In a study today in the journal Nature Communications, UConn Health researchers identify defects that cause Angelman syndrome.
April 24, 2017 | Colin Poitras
Is Sitting the New Smoking?
Make movement part of your workday, says a UConn Health ergonomist.
April 13, 2017 | Jennifer Garza, UConn Health
New Engineering and Science Building Nearing Completion
The building will be the first to utilize an 'open lab' concept – the idea that shared research space and an open floor plan foster collaboration.
April 7, 2017 | Colin Poitras
Health Insurance Plans ‘Too Complicated to Understand’
A new survey by the Health Disparities Institute of UConn Health shows that many patients across Connecticut are struggling to understand their complex, jargon-filled private health insurance plans.
April 5, 2017 | Lauren Woods
Allergy Season is Here
A UConn ENT specialist offers advice to allergy sufferers on how best to make it through allergy season.
April 4, 2017 | Lauren Woods
Stem Cell Fabric Innovation Regrows Rotator Cuffs
A team of researchers from UConn Health has found a way to regenerate rotator cuff tendons after they’re torn, using a nano-textured fabric seeded with stem cells.
April 3, 2017 | Kim Krieger
Fitness Tracker Saves Patient’s Life
After her Fitbit alerted her to serious heart trouble, 73-year-old Patricia Lauder was successfully treated at UConn Health's Calhoun Cardiology Center.
April 3, 2017 | Lauren Woods
Expert Discusses First and Only Drug Approved for Progressive Multiple Sclerosis
Dr. Matthew Tremblay, who specializes in the care of patients with multiple sclerosis at UConn Health, discusses a new drug just approved by the FDA.
March 30, 2017 | Lauren Woods
Mark of Malignancy Identified in Prostate Cancer
Researchers at UConn Health have identified a protein that appears to indicate how aggressive a prostate cancer will be, potentially leading the way to new treatments.
March 30, 2017 | Kim Krieger
Sick Stem Cells Point to Better MS Drugs
UConn Health researchers think they know why a particularly aggressive form of multiple sclerosis has so far proved unresponsive to drug treatments. They hope this knowledge will help develop better treatments.
March 28, 2017 | Kim Krieger